CSF2 and Sepsis: Surface expression of mHLA-DR on CD14+ blood monocytes has been used as a diagnostic marker of the onset of an immunosuppressive state in several studies.13,18,21,68 However, the recognition that immunosuppressive processes are present at the onset of sepsis should challenge the timing of GM-CSF implementation in addition to the end-points evaluated.